IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,980 | -26.9% | 1,534 | +13.1% | 0.00% | 0.0% |
| Q2 2023 | $9,546 | -36.7% | 1,356 | -45.1% | 0.00% | -50.0% |
| Q1 2023 | $15,092 | -26.4% | 2,470 | -23.0% | 0.00% | -33.3% |
| Q4 2022 | $20,493 | +127.7% | 3,207 | +228.9% | 0.00% | +50.0% |
| Q3 2022 | $9,000 | -18.2% | 975 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -38.9% | 1,020 | -8.0% | 0.00% | -33.3% |
| Q1 2022 | $18,000 | -14.3% | 1,109 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | +950.0% | 1,125 | +1462.5% | 0.00% | +200.0% |
| Q3 2021 | $2,000 | -33.3% | 72 | -40.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | – | 120 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | +92.9% | 1,000 | +100.0% | 0.01% | +60.0% |
| Q4 2019 | $14,000 | +100.0% | 500 | -33.3% | 0.01% | +66.7% |
| Q1 2019 | $7,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |